Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting, 3918 [2011-1244]
Download as PDF
3918
Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Characterization of
Pandemic Flu.
Date: February 11, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Ellen S. Buczko, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, Room 3145 MSC 7616,
Bethesda, MD 20892–7616, 301–451–2676,
ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1246 Filed 1–20–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director; Notice of Meeting
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
National Science Advisory Board for
Biosecurity (NSABB).
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: February 10, 2011.
Time: 8:30 a.m. to 4 p.m. Eastern Daylight
Time (Times are approximate and subject to
change).
Agenda: Presentations and discussions
regarding: (1) Update on NSABB Working
Group activities on Codes of Conduct;
Culture of Responsibility; International
Engagement; Journal Review Policies; and
Outreach and Education activities, including
as well as possible Board review/approval of
Working Group reports; (2) planning for
future NSABB meetings and activities; and
(3) other business of the Board.
Place: National Institutes of Health,
Building 31, Center Drive, 6th Floor,
Conference Room 6, Bethesda, Maryland
20892.
VerDate Mar<15>2010
13:45 Jan 20, 2011
Jkt 223001
Contact Person: Ronna Hill, NSABB
Program Assistant NIH Office of
Biotechnology Activities, 6705 Rockledge
Drive, Suite 750, Bethesda, Maryland 20892,
(301) 496–9838, hillro@od.nih.gov.
Under the authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service Act,
as amended, the Department of Health and
Human Services established the NSABB to
provide advice, guidance and leadership
regarding federal oversight of dual use
research, defined as biological research that
generates information and technologies that
could be misused to pose a biological threat
to public health and/or national security.
The meeting will be open to the public,
however pre-registration is strongly
recommended due to space limitations.
Persons planning to attend should register
online at: https://oba.od.nih.gov/biosecurity/
biosecurity_meetings.html or by calling
Palladian Partners, Inc. (Contact: Joel
Yaccarino at 301–650–8660). Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, please contact the person
listed under Contact Person at least 10 days
in advance of the meeting, to allow NIH as
much time as possible to process your
request.
This meeting will also be webcast. To
access the webcast, as well as the draft
meeting agenda and pre-registration
information, connect to: https://
oba.od.nih.gov/biosecurity/biosecurity
_meetings.html. Please check this site for
updates or contact the person listed under
Contact Person.
Any member of the public interested in
presenting oral comments relevant to the
mission of the NSABB at the meeting may
notify the Contact Person listed on this notice
at least 10 days in advance of the meeting.
Interested individuals and representatives of
an organization should submit, their name,
professional title, name of the organization
represented, and the topic of their oral
comments. Only one representative of an
organization will be permitted to present oral
comments. Presenters should submit to OBA
both printed and electronic copies of their
comments. In addition, any interested person
may file written comments relevant to the
mission of the NSABB. In order to be
distributed to Board members in advance of
the meeting, written comments must be
received at least 10 days in advance of the
meeting and should be sent via e-mail to
nsabb@od.nih.gov with ‘‘NSABB Public
Comment’’ as the subject line or by regular
mail to the person listed on this Federal
Register notice.
Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1244 Filed 1–20–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
General Medical Sciences Council,
January 27, 2011, 8:30 a.m. to January
28, 2011, 5 p.m., National Institutes of
Health, Natcher Building, Conference
Rooms E1 & E2, 45 Center Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
December 20, 2010, 75 FR 79386.
The open session of the meeting, held
on January 28, 2011, has been changed
to begin at 8 a.m.
The meeting is partially closed to the
public.
Dated: January 10, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–1198 Filed 1–20–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; P30
Review.
Date: February 3, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan L Sullivan, PhD,
Scientific Review Officer, National Institute
of Deafness and Other Communication
E:\FR\FM\21JAN1.SGM
21JAN1
Agencies
[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3918]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1244]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities, Office of Science Policy,
Office of the Director; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the meeting of the
National Science Advisory Board for Biosecurity (NSABB).
Name of Committee: National Science Advisory Board for
Biosecurity.
Date: February 10, 2011.
Time: 8:30 a.m. to 4 p.m. Eastern Daylight Time (Times are
approximate and subject to change).
Agenda: Presentations and discussions regarding: (1) Update on
NSABB Working Group activities on Codes of Conduct; Culture of
Responsibility; International Engagement; Journal Review Policies;
and Outreach and Education activities, including as well as possible
Board review/approval of Working Group reports; (2) planning for
future NSABB meetings and activities; and (3) other business of the
Board.
Place: National Institutes of Health, Building 31, Center Drive,
6th Floor, Conference Room 6, Bethesda, Maryland 20892.
Contact Person: Ronna Hill, NSABB Program Assistant NIH Office
of Biotechnology Activities, 6705 Rockledge Drive, Suite 750,
Bethesda, Maryland 20892, (301) 496-9838, hillro@od.nih.gov.
Under the authority of 42 U.S.C. 217a, Section 222 of the Public
Health Service Act, as amended, the Department of Health and Human
Services established the NSABB to provide advice, guidance and
leadership regarding federal oversight of dual use research, defined
as biological research that generates information and technologies
that could be misused to pose a biological threat to public health
and/or national security.
The meeting will be open to the public, however pre-registration
is strongly recommended due to space limitations. Persons planning
to attend should register online at: https://oba.od.nih.gov/biosecurity/biosecurity_meetings.html or by calling Palladian
Partners, Inc. (Contact: Joel Yaccarino at 301-650-8660).
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations,
please contact the person listed under Contact Person at least 10
days in advance of the meeting, to allow NIH as much time as
possible to process your request.
This meeting will also be webcast. To access the webcast, as
well as the draft meeting agenda and pre-registration information,
connect to: https://oba.od.nih.gov/biosecurity/biosecurity_meetings.html. Please check this site for updates or contact the
person listed under Contact Person.
Any member of the public interested in presenting oral comments
relevant to the mission of the NSABB at the meeting may notify the
Contact Person listed on this notice at least 10 days in advance of
the meeting. Interested individuals and representatives of an
organization should submit, their name, professional title, name of
the organization represented, and the topic of their oral comments.
Only one representative of an organization will be permitted to
present oral comments. Presenters should submit to OBA both printed
and electronic copies of their comments. In addition, any interested
person may file written comments relevant to the mission of the
NSABB. In order to be distributed to Board members in advance of the
meeting, written comments must be received at least 10 days in
advance of the meeting and should be sent via e-mail to
nsabb@od.nih.gov with ``NSABB Public Comment'' as the subject line
or by regular mail to the person listed on this Federal Register
notice.
Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1244 Filed 1-20-11; 8:45 am]
BILLING CODE 4140-01-P